Purchase Order 75N92020P00269

<p>The National Heart Lung and Blood Institute awarded a purchase order to Taconic Biosciences, Inc. for $21,875 on September 21, 2020, to conduct knockin of GFP into the MYO10 locus in order to study myosin function in different tissues. Work is performed in Rensselaer, New York. The order carries firm fixed price terms and an ultimate completion date of October 21, 2020.</p>

The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $996,710 firm fixed price purchase order to Lumicks USA Inc. to generate HBB, HBBS, and HBBE knock-in mice. The solicitation sought a contractor capable of generating transgenic and knock-in mouse models using CRISPR/Cas9 or other genome editing technologies for biomedical research purposes. No set-aside designation or incumbent contractor was specified. Lumicks will...

<p>The National Institute of Child Health and Human Development issued a purchase order to Cyagen US Inc. for $97,577 on September 14, 2020, for turboknockout mouse gene targeting services. Work is performed in Santa Clara, California. The order is firm fixed price with an ultimate completion date of June 22, 2021. The underlying solicitation was posted August 12, 2020, with a due date of August 21, 2020.</p>

<p>The Office of Logistics and Acquisition Operations awarded a firm fixed price purchase order to Jackson Laboratory for $27,000 on February 11, 2019 to generate and deliver a knock-in mouse line carrying a unique point mutation in exon 5 of the ZBTB20 gene (NM_001164342). Work is performed in Bar Harbor, Maine. The order has an ultimate completion date of February 17, 2020. The award originated from a special notice solicitation posted January 24, 2019 with a due date of February 7, 2019.</p>

The Department of Health and Human Services' National Institutes of Health National Institute of Child Health and Human Development awarded a $121,347 firm fixed price purchase order to Cyagen Biomodels LLC of Santa Clara, California. The contract is for the generation of conditional knock-in and knock-out mouse models to support the agency's research focusing on the development of the mammalian hematopoietic system and study of signal transduction molecules and pathways that regulate T...

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $25,000 firm fixed price purchase order to Cyagen Biomodels LLC for a project to conditionally knockout mouse WNK1 and STK10 genes using CRISPR/Cas9 technology. Work will be performed by Cyagen Biomodels LLC Division in Santa Clara, California over a period of four months concluding in late December 2023. The award was made to the prime contractor Cyagen...

The National Institute of Child Health and Human Development (NICHD) awarded a $48,455 firm fixed-price purchase order to Cyagen US Inc., a biotechnology company based in Santa Clara, CA, to provide gene targeting services. The award is for the generation of conditional knockout and knockin mouse models to support NICHD's research on T cell receptor signaling and the development of the mammalian hematopoietic system. This award was made without a set-aside designation and has an ultimate...

Kamtek Inc. has been awarded a $24,510 firm fixed price purchase order by the National Institutes of Health's National Human Genome Research Institute to provide transgenic mouse line creation and cryopreservation services for one year. Under this contract, Kamtek will create and cryopreserve transgenic mouse lines for future use in support of NHGRI's research efforts. The work will be performed by Kamtek in Frederick, Maryland and no subcontractors were identified. This purchase order draws...

This federal contract award to Ozgene PTY LTD, an Australian company, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The $57,600 firm-fixed-price contract was for the generation of conditional gene knockout and knockin mouse models to support biomedical research. Ozgene, as the prime contractor, will provide gene targeting vector design and creation, mouse...

This federal contract award to Ozgene PTY LTD, an Australian company, is for the provision of gene targeting vectors, mouse backcrossing, and the creation of gene knockout and gene knock-in mice to support biomedical research at various institutes and centers within the U.S. Department of Health and Human Services' National Institutes of Health (NIH). The specific contract award is for $8,183 from the National Institute of Allergy and Infectious Diseases (NIAID) for the task &quot;BREEDING TO...